27 Dec How a Biotechnology Company Is Disrupting Non-Opioid Analgesics
Opioid abuse has indeed turned out to be a national health problem in the United States, having accounted for about 800,000 deaths between 1999 and 2023 due to overdose.
Such a trend puts the difficult requirements on innovating new pain relieving agents that are not addictive. A Biotechnology company has sized a promising opportunity by developing a novel kind of non-opioid analgesics. These analgesics would be an ideal alternative for chronic pain patients who find such medications effective but want a more natural and successful solution.
Let’s find out how a biotechnology company revolutionizes pain relief interventions through innovative non-opioid substitutes.
TOLERANCE AND ADDICTION OF OPIOIDS
Opioids attach to opioid receptors in the brain, spinal cord, and other parts of the body. In order to prevent pain signals, they decrease pain messages and activate reward regions. Additionally, opioids suppress other nerve cell functions like respiration, heart rate, and awareness.
With time, the body used to these drugs, and the efficacy of pain relief fades. This is termed ‘tolerance’ and it implies that higher doses of the same medicine are needed to attain the same level of pain relief.
The cycle of tolerance and addiction worsened the already worsening opioid crisis. It started in the late 1990s when there was a significant increase in opioid prescriptions, which also resulted in an increase in overdose deaths associated with prescriptions by at least 1999.
The second wave, which saw a sharp rise in heroin overdose deaths, occurred in 2010. Large increases in overdose deaths with synthetic opioids, mainly illegally manufactured fentanyl, marked the start of the third wave in 2013.
The unfoldment of the opioid problem is regarding huge and worrisome figures. Drug overdose deaths are rising in 2021 by more than six times higher than in 1999. The rise in drug overdose deaths between 2020 and 2021 is in excess of 16%. Opioids accounted for more than three-quarters of the approximately 107,000 deaths from drug overdoses in 2021.
THE ROLE OF A BIOTECHNOLOGY COMPANY IN CREATING NON-OPIOID SOLUTIONS
The opioid crisis has had a major impact on the way a biotechnology company approaches the formulation of painkillers. There has been a move toward developing safer, non-addictive alternatives to opioids because of worries about their abuse and addiction.
Even though there have not been any new oral painkillers released in the last 25 years, the industry has seen a surge in activity as some biotechnology companies have made strides toward developing possible novel treatments. These pain relief medicines act directly on pain receptors or pathways and offer pain relief without addiction risk.
The goal of the biotechnology companies is not only to replace opioids but also to create smarter and more effective pain relief support ingredients that treat pain at its source.
MAIN INNOVATIONS IN BIOTECHNOLOGY
Biotechnology companies are at the forefront of emerging innovative non-opioid painkillers and powerful alternatives to traditional opioid treatments. An overview of some major Recent biotechnology innovations are:
TARGETED THERAPIES
Instead of depressing the whole nervous system, biotechnology companies produce drugs that will mute specific pain receptors within the body. This offers a much-needed alternative to opioid medicines by delivering more accurate pain relief with fewer adverse effects.
GENE THERAPY
Gene therapy is also one of the recent biotechnology innovations. The goal of gene treatments is to change the genetic basis of the body’s pain signals. The biotech firms may be able to lessen or even eradicate chronic pain by modifying the genes that determine how pain is perceived, providing relief for ailments for which there are now few effective treatments.
NON-ADDICTIVE SUBSTANCES
The next noteworthy biotechnology innovation is non-addictive substances. Several biotech companies are currently developing compounds that produce effective pain relief without the associated addictive properties of opioids. Such compounds shall engage pain pathways devoid of an addictive risk thereby promoting safeness in the treatment of patients with chronic pain in the long term.
BIOLOGICS AND PEPTIDE DRUGS
The peptide-based drugs are built on small chains of amino acids while biologics are huge compounds or cells from something alive. These types of therapies modify the pain-signaling pathways within the bodies of individuals and as such could have some useful benefits but would probably not have the high probability of creating dependence.
These recent biotechnology innovations and the advanced research presently going on would surely brighten the future of pain management and decrease the dependency on opioids.
WINTERS BIOTECHNOLOGY LEADS THE WAY IN NON-OPIOID ANALGESICS FORMULATION
Winters Biotechnology has a considerable role to play in the area of non-opioid pain relief.
And we are honored to be a part of the revolutionary advancement. Our goal is simple yet impactful: to develop natural, safe, and efficient alternatives to traditional opioids in order to transform pain management and enhance patient results.
CONOCB2 is the next variant of the Conolidine alkaloid and one of the innovative products we have crafted. In the bark of the Tabernaemontana divaricata tree, Conolidine has shown encouraging analgesic effects.
We at our biotechnology company have improved this substance to produce a formulation that affects the endocannabinoid system and targets opioid receptors in the brain. We can provide a more complete pain relief solution because of this dual-action strategy.
Our efforts are focused on bringing these products to market and making them available globally through collaborations with top manufacturers. We are eager to keep pushing these advancements forward since our biotechnology company is opening the door for safer, more efficient pain management options by emphasizing natural alternatives.
CONCLUSION
Biotechnology companies are at the forefront of creating revolutionary alternatives that provide more effective solutions while avoiding addiction risks. These new technologies alter our perception of pain control and instill hope among those suffering from chronic pain. Stay updated on all these groundbreaking advances by reading the latest biotechnology news and updates from our biotechnology company.